Navigation Links
MedQuist Reports First Quarter 2008 Results
Date:5/12/2008

of period 161,582 175,412

Cash and cash equivalents - end of period $152,711 $173,409

Supplemental cash flow information:

Cash paid for income taxes $95 $93

Accommodation payments paid with credits $404 $689

MedQuist Inc. and Subsidiaries Reconciliation of GAAP financial measures to the aforementioned non-GAAP

financial measures

(In thousands, except per share amounts)

Unaudited

Three months ended

March 31,

2008 2007

GAAP Operating (Loss) $(5,434) $(3,296)

Add: Cost of investigation and legal

proceedings, net 6,398 1,741

Non-GAAP Operating Profit (Loss), excluding

Cost of investigation and legal

proceedings, net $964 $(1,555)

Operating profit, excluding Cost of investigation and legal proceedings, is a financial measure not computed in accordance with United States generally accepted accounting principles, or GAAP. The Company believes that this non- GAAP measure, when presented in conjunction with comparable GAAP measures, is useful to both management and investors in analyzing the Company's ongoing business and operating performance. The Company believes that providing the non-GAAP information to investors, in addition to the GAAP presentation, allows investors to view the Company's financial results in the way that management views financial results. Management believes Operating profit, excluding Cost of investigation and legal proceedings is useful as a supplemental measure of the
'/>"/>

SOURCE MedQuist Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. QLT reports initial proof of concept data for punctal plug delivery technology
2. Neurobiological Technologies Reports Third Quarter Financial Results
3. Bionovo Reports First Quarter 2008 Financial Results
4. WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders Meeting
5. Cardium Reports on First Quarter 2008 Highlights and Financial Results
6. Novavax Reports First Quarter 2008 Financial Results
7. Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
8. Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
9. Pharmos Corporation Reports 2008 First Quarter Results
10. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
11. Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...lif.,Nov.24/PRNewswire-FirstCall/--GenomicHealth,I...omicHealth,sExecutiveChairman,willpresentatthe21st...yonTuesday,December1,2009at10:00a.m.ET. ,, Toac...entation,visittheInvestorRelationssectionofGenomic...m .Pleaseconnecttothewebsiteatleast15minutespriort...
(Date:11/24/2009)... Program Connects Customers with Partners Valid... DNA Genotek Products , O...k , a leading provider of products for biological ...today announced its new global partner program. Th...Genotek,s partner community and is designed to hel...
(Date:11/24/2009).../PRNewswire-FirstCall/--CellTherapeutics,Inc.(CTI)...nnualPiperJaffrayHealthCareConference.Theconferenc...l. ,, CTIwillpresentonTuesday,December1at11:00a...tofCTI,spresentationwillbeavailableat www.cellther...erwards. , ,PiperJaffrayHealthCareConference,NewY...
(Date:11/23/2009)... can think of it as origami very high-tech origam...ve developed a technique for fabricating three-dim...om thin films by coupling photolithography and a s...ns. , The films, only a few microns thick, offer ...hicker pieces of the same material. , "This is a ...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2
...enetics (Nasdaq: DCGN ) announced today that it ...ic financial institution, pursuant to which NBI ha...n aggregate price of $11 million. Pursuant to the ...BI to sell the securities back to the company at a...t option to require deCODE to repurchase the secur...
...rtual Lecture and Podcast for Healthcare Professio...on about Clostridium difficile infection (CDI) i...f CDI is changing and has been marked by increasin... epidemic strain continues to be reported in an ex...d worldwide. , , To address the need for curren...
...IS, Jan. 20 ,BASF and Monsanto Company (NYSE: MO...t to accelerate the development of the next-genera...ucts. Both parties will participate in the,develop...e with herbicide-,resistant cropping systems. Furt... Researchers are able to make herbicide-resist...
Other Biology Technology:deCODE Sells Auction Rate Securities 2deCODE Sells Auction Rate Securities 3Clostridium difficile Infection: Current Challenges and Controversies 2BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies 2BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies 3BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies 4
(Date:11/24/2009)..., The presence of increased body fat, and there...he blood, hinders the loss and maintenance of body...versity of Navarra conducted by Estbaliz Goyeneche... The project, entitled "A nutrigenetic and nutrige...ght and inflammation," examines how the individual...
(Date:11/23/2009)...lied mathematicians dissected the morphology of th...stic long leaf with a saddle-like arc midsection a...ple cause of the lily,s fan-like shapeelastic rela...growthwas revealed by using an equally simple tech... postdoctoral student at Harvard,s School of Engin...
(Date:11/23/2009)... gathered this week for the seventh annual Nationa...is year,s topic, "Synthetic Biology," brought toge...s to explore the engineering, scientific, and soci...tic biology. , Bonnie L. Bassler, professor of m...year,s conference chair, challenged the attendees ...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Regence Launches Effort to Further Health Care Debate 51852 1Regence Launches Effort to Further Health Care Debate 51852 2Regence Launches Effort to Further Health Care Debate 51852 3Pamela Davis Announced as Recipient of ACFE Sentinel Award 51847 1Pamela Davis Announced as Recipient of ACFE Sentinel Award 51847 2National Advocacy Organization Representing Home Oxygen Patients Praises Introduction of Medicare Home Oxygen Therapy Act 51843 1National Advocacy Organization Representing Home Oxygen Patients Praises Introduction of Medicare Home Oxygen Therapy Act 51843 2
...g of a license agreement between the CSIRO/Austral...tgrains Pty Ltd has paved the way for large scale ...oped by CSIRO using conventional plant breeding te...ures Flagship, Dr Bruce Lee., "It contains more th... found in wheat or oats, as well as resistant star...
...Huge numbers of fish, seabirds, and other marine a...ing inadvertently caught during fishing operations...ing challenge to the fishing industry, regulatory ...l would compensate for bycatch by reducing other i...gests that this strategy could end up doing more h...
.... -- A L,Oreal USA Fellowship for Women in Science...na Laura Lapham, a postdoctoral research assistant...f Oceanography, and this year, one of just five yo...e prestigious $40,000 prize. , The L,Oreal USA Fe...ered by the American Association for the Advanceme...
Other Biology News:New study raises concerns about proposed mitigation strategy for marine bycatch 2'Women in Science' fellowship to fund postdoc's study of deep-sea methane 2'Women in Science' fellowship to fund postdoc's study of deep-sea methane 3
Mouse Anti-Duck IgY Light Chain Monoclonal Antibody, Unconjugated, Clone 14A3 from AbD Serotec
Mouse Anti-NEUROFILAMENTS 140+160 KD Monoclonal Antibody, Unconjugated, Clone BIO-46H from AbD Serotec
Rat Anti-Rat RT1Au (Class I Polymorphic) Monoclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-Simian Virus 5 Monoclonal Antibody, Unconjugated from AbD Serotec
Biology Products: